Skip to content

A pilot "SCIATICA" study - Stem Cell Intra-Articular Therapeutic Injection for Carpal Affections

A pilot "SCIATICA" study - Stem Cell Intra-Articular Therapeutic Injection for Carpal Affections

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-14005353
Enrollment
Unknown
Registered
2014-09-11
Start date
2014-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with post-traumatic chronic wrist pain, with imaging and previous arthroscopic evidence of wrist carpal bone chondral defects who opt for active treatment

Interventions

Case series:Autologous mesenchymal stem cell intra-articular injection

Sponsors

Dr. WL Tse
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Wrist pain of mechanical origin(post-traumatic); 2. The pain cannot be relieved by treating other underlying defects other than carpal affections; 3. Patients with imaging and previous arthroscopic evidence of wrist carpal bone chondral defects; 4. Absence of any local or general infection; 5. Hematologic and biochemical analyses with no significant alterations that contraindicate intervention; 6. Patient who is able to understand the nature the study and provide informed written consent.

Exclusion criteria

Exclusion criteria: 1. Age older than 75 or younger than 18 years old or legally dependent; 2. Patients with past history of hematologic disorders; 3. Signs of infection or positive serology for HIV, HBV, HCV, or syphilis; 4. Congenital or acquired diseases leading to significant wrist deformities that may interfere with cell application or interpretation of results; 5. Pregnancy or breast, feeding, Neoplasia, Immunosuppression, Participation in another clinical trial or treatment with another investigational product within 30 days before inclusion in the study; 6. Patients with alcoholism/drug abuse; 7. Other medical conditions that may discourage participation in the study.

Design outcomes

Primary

MeasureTime frame
Diagnostic radiological (MRI)assessments will be done at post-injection 6th month.;

Secondary

MeasureTime frame
VAS, functional wrist score, PRWE, DASH, Power, ROM at post-injection 3rd, 6th, 12nd and 24th month;

Countries

China

Contacts

Public ContactDr WL Tse
tse@ort.cuhk.edu.hk+852 26322065

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026